Plasma concentrations over time2
A graph illustrating how INVEGA TRINZA® sustained plasma concentration for up to 3 months

Due to the difference in median pharmacokinetic profiles between the 2 products (INVEGA TRINZA® and INVEGA SUSTENNA® [paliperidone palmitate]), caution should be exercised when making a direct comparison of their pharmacokinetic properties.2

Correlation to clinical effect has not been established.

References: 1. INVEGA TRINZA® [prescribing information]. Titusville, NJ: Janssen Pharmaceuticals, Inc.; February 2017. 2. Data on file. Janssen Pharmaceuticals, Inc., Titusville, NJ.